Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Sale | 2024-12-17 6:10 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 165 | $0.3523 | $58 | 22,563 (Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:08 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 3,117 | $0.36294 | $1,131 | 7,791,655 (Indirect Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:06 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 577 | $0.35871 | $207 | 28,602 (Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:04 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 430 | $0.35587 | $153 | 32,093 (Direct) | View |
| 2024-12-16 Sale | 2024-12-17 6:03 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 430 | $0.35306 | $152 | 36,601 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:55 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 6,272 | $0.55 | $3,450 | 19,011 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:55 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 6,863 | $0.55 | $3,775 | 23,770 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:54 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 7,175 | $0.55 | $3,946 | 28,278 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:54 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 7,175 | $0.55 | $3,946 | 20,279 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:53 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 5,556 | $0.55 | $3,056 | 19,601 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-30 Exercise | 2025-06-30 4:30 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 1,693 | $0 | 20,317 (Direct) | View |
| 2025-06-14 Exercise | 2025-06-16 7:03 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 68 | $0 | 1,989 (Direct) | View |
| 2025-06-14 Exercise | 2025-06-16 7:02 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 68 | $0 | 2,489 (Direct) | View |
| 2025-06-14 Exercise | 2025-06-16 7:01 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 382 | $0 | 488,122 (Direct) | View |
| 2025-06-14 Exercise | 2025-06-16 7:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 68 | $0 | 2,207 (Direct) | View |
| 2025-05-31 Exercise | 2025-06-02 7:10 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 1,693 | $0 | 20,317 (Direct) | View |
| 2025-04-30 Exercise | 2025-05-01 7:23 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 1,693 | $0 | 20,317 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:08 pm | N/A 2034-07-22 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 1,875 | $0 | 1,875 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:08 pm | N/A 2034-07-22 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 6,250 | $0 | 6,250 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:07 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,500 | $0 | 2,500 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:06 pm | N/A 2034-07-22 | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. See Remarks | 1,875 | $0 | 1,875 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:04 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 2,500 | $0 | 2,500 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:02 pm | N/A 2034-07-22 | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 1,875 | $0 | 1,875 (Direct) | View |
| 2025-03-31 Exercise | 2025-04-01 6:02 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 1,693 | $0 | 20,317 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-17 6:38 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 65 | $0 | 1,989 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-17 6:37 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 65 | $0 | 2,207 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-17 6:36 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 65 | $0 | 2,489 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-17 6:35 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 379 | $0 | 488,122 (Direct) | View |
| 2025-02-28 Exercise | 2025-03-04 9:21 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 1,693 | $0 | 20,317 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 5:28 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 27,089 | $0 | 325,077 (Direct) | View |
| 2025-01-15 Option Award | 2025-01-16 08:04 am | N/A 2035-01-15 | BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director | 44,000 | $0 | 44,000 (Direct) | View |
Ownership | 2025-01-16 08:03 am | N/A 2033-12-08 | BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director | 0 | $0 | 15,000 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-10 8:03 pm | N/A 2035-01-07 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 660,000 | $0 | 660,000 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-10 8:01 pm | N/A 2035-01-07 | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-10 8:00 pm | N/A 2035-01-07 | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 4:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 27,089 | $0 | 325,077 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:10 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 521 | $0 | 22,563 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:08 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 6,110 | $0 | 7,791,655 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:06 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,083 | $0 | 28,602 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:04 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,083 | $0 | 32,093 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 6:03 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 1,083 | $0 | 36,601 (Direct) | View |
| 2024-11-30 Exercise(A) | 2024-12-04 4:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 27,089 | $0 | 325,077 (Direct) | View |
| 2024-11-21 Option Award | 2024-12-03 4:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 297,988 | $0 | 325,087 (Direct) | View |
| 2024-11-30 Exercise | 2024-12-03 4:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 27,089 | $0 | 325,087 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:06 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director | 325,077 | $0 | 325,077 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 21,250 | $0 | 19,011 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 21,250 | $0 | 23,770 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:54 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 21,250 | $0 | 28,278 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:54 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 21,250 | $0 | 20,279 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:53 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 21,250 | $0 | 19,601 (Direct) | View |